Clinical TrialsSearch results
Number of results: 713
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- bezafibrate for post operated bilirary atresia
- Biliary Atresia
- Terui Keita
- 2021-05-06
Recruiting
- A phase Ib study of durvalumab (MEDI4736) tremelimumab combined with particle therapy in advanced hepatocellular carcinoma patients with macrovascular invasion
- hepatocellular carcinoma
- Ogasawara Sadahisa
- 2021-04-22
Other
- Phoenix study
- Metastatic or recurrent pancreatic cancer
- Ikeda Masafumi
- 2021-04-15
Recruiting
- Validation study of CAST score for adult PCAS patients before intiating TTM
- PCAS patients
- Nishikkimi Mitsuaki
- 2021-04-12
Recruiting
- HN LET
- Head and neck cancer
- Koto Masashi
- 2021-04-07
Recruiting
- A multicenter prospective adapttive trial (Non-comparative phase2 and non-inferiority phase3 study) of underwater endoscopic miucosal resection (UEMR) compared to endoscopic submucosal dissection (ESD) for early
colorectal cancer.
- early colorectal cancer
- Katou Naoya
- 2021-04-06
Recruiting
- JCOG2007: A Multicenter Randomized Phase III Study comparing Pembrolizumab + Platinum Combination Chemotherapy with Nivolumab + Ipilimumab + Platinum Combination Chemotherapy for Treatment-naive Advanced Non-Small Cell Lung Cancer without Driver Gene alteration
- Treatment-naive advanced non-small cell lung cancer without driver gene alteration
- OKAMOTO Isamu
- 2021-04-06
Recruiting
- Development of the measurement of the blood brain barrier breakdown and myelin damage by brain MRI in healthy controls abd patients with multiple sclerosis and neuromyelitis optica spectrum disorder.
- multiple sclerosis, neuromyelitis optica sspectrum disorders,healthy controls
- Masuda Hiroki
- 2021-04-02
Completed
- Imagery rescripting for Chronic Pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-03-25
Completed
- Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
- Hepatocellular Carcinoma
- Tanigawa Takahiko
- 2021-03-23